HK1166953A1 - Compositions and methods of use - Google Patents

Compositions and methods of use

Info

Publication number
HK1166953A1
HK1166953A1 HK12107740.4A HK12107740A HK1166953A1 HK 1166953 A1 HK1166953 A1 HK 1166953A1 HK 12107740 A HK12107740 A HK 12107740A HK 1166953 A1 HK1166953 A1 HK 1166953A1
Authority
HK
Hong Kong
Prior art keywords
compositions
methods
Prior art date
Application number
HK12107740.4A
Other languages
English (en)
Chinese (zh)
Inventor
．奇塔利亞
．普拉巴克蘭
．巴爾蒂
．賈亞蒂拉克
．付
Original Assignee
瓦納斯腫瘤學有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 瓦納斯腫瘤學有限公司 filed Critical 瓦納斯腫瘤學有限公司
Publication of HK1166953A1 publication Critical patent/HK1166953A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/898—Orchidaceae (Orchid family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/11—Pteridophyta or Filicophyta (ferns)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK12107740.4A 2009-01-14 2012-08-07 Compositions and methods of use HK1166953A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20514409P 2009-01-14 2009-01-14
PCT/US2010/021046 WO2010083311A2 (fr) 2009-01-14 2010-01-14 Compositions et procédés d'utilisation

Publications (1)

Publication Number Publication Date
HK1166953A1 true HK1166953A1 (en) 2012-11-16

Family

ID=42340288

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12107740.4A HK1166953A1 (en) 2009-01-14 2012-08-07 Compositions and methods of use

Country Status (9)

Country Link
US (2) US10478464B2 (fr)
EP (1) EP2381950B1 (fr)
JP (1) JP5748670B2 (fr)
KR (1) KR20110118145A (fr)
CN (1) CN102348461B (fr)
AU (1) AU2010204706A1 (fr)
CA (1) CA2749496A1 (fr)
HK (1) HK1166953A1 (fr)
WO (2) WO2010083311A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2749496A1 (fr) * 2009-01-14 2010-07-22 Vanas Oncology Compositions et procedes d'utilisation
WO2013039880A1 (fr) * 2011-09-12 2013-03-21 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Biomarqueurs et cibles thérapeutiques du cancer hépatocellulaire
KR101756905B1 (ko) 2016-10-24 2017-07-11 대구가톨릭대학교산학협력단 석송강 추출물 또는 이로부터 분리된 화합물을 포함하는 알츠하이머병의 예방 또는 치료용 조성물-ⅱ

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL121165A0 (en) * 1997-06-26 1997-11-20 Yissum Res Dev Co Pharmaceutical compositions containing carboxylic acids and derivatives thereof
US6639089B2 (en) * 2000-11-08 2003-10-28 Soda Aromatic Co., Ltd. Anticancer agents, perfumes or foods and drinks
CN101301407B (zh) * 2008-07-02 2010-09-08 刘书田 一种治疗关节炎、脉管炎的药物
CA2749496A1 (fr) * 2009-01-14 2010-07-22 Vanas Oncology Compositions et procedes d'utilisation

Also Published As

Publication number Publication date
EP2381950A4 (fr) 2012-08-22
CN102348461A (zh) 2012-02-08
JP5748670B2 (ja) 2015-07-15
US10478464B2 (en) 2019-11-19
KR20110118145A (ko) 2011-10-28
CN102348461B (zh) 2014-08-20
EP2381950B1 (fr) 2013-11-13
US20100209543A1 (en) 2010-08-19
WO2010083311A3 (fr) 2010-11-25
WO2021086610A1 (fr) 2021-05-06
CA2749496A1 (fr) 2010-07-22
WO2010083311A2 (fr) 2010-07-22
EP2381950A2 (fr) 2011-11-02
US20200046786A1 (en) 2020-02-13
JP2012515171A (ja) 2012-07-05
AU2010204706A1 (en) 2011-08-04

Similar Documents

Publication Publication Date Title
HRP20180497T1 (hr) Antimikrobni pripravci i odgovarajući postupci njihove upotrebe
EP2536756A4 (fr) Compositions relatives a l'albumine serique humaine et leurs methodes d'utilisation
EP2584897A4 (fr) Compositions contenant du resvératrol et procédés d'utilisation
IL217280A0 (en) Compositions comprising combinations of phyto-cannabinoids and uses thereof
HK1194071A1 (en) Certain triazolopyrazines, compositions thereof and methods of use therefor
PL2448581T3 (pl) Kompozycje terapeutyczne i odnośne sposoby ich stosowania
EP2456787A4 (fr) Compositions de cytokine et leurs méthodes d utilisation
EP2596112A4 (fr) Compositions d'acétylcystéine et méthodes d'utilisation correspondantes
EP2384120A4 (fr) Compositions adjuvantes et méthodes d'utilisation
EP2231665A4 (fr) Nouvelles compositions et procédés d'utilisation
EP2506709A4 (fr) Compositions d'amantadine et procédés d'utilisation associés
EP2464227A4 (fr) Composés et leurs procédés d utilisation
EP2515647A4 (fr) Compositions de phéromones et leurs procédés d'utilisation
EP2496240A4 (fr) Compositions d'apatite et procédés d'utilisation
EP2622029A4 (fr) Compositions de désencrage et leurs procédés d'utilisation
IL247929B (en) Stable compositions of 595–sns and methods for their preparation
EP2421923A4 (fr) Compositions d'encre et leurs procédés d'utilisation
EP2416796A4 (fr) Compositions de dnase modifiée et procédés d'utilisation de celles-ci
PL2498613T3 (pl) Kompozycje biobójcze i sposoby ich stosowania
HK1166953A1 (en) Compositions and methods of use
HK1174620A1 (zh) 吲唑基取代的二氫異噁唑並吡啶及其使用方法

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20200112